Daniele Stracka
Director | Zurich, CH
Focus Area
Daniele has a focus on Market Access and Market & Customer Insights. His experience includes the design of strategic tools to support payer engagement, as well as the development and roll out of negotiation pathways and targeted affiliate trainings to optimize payer negotiation outcomes across several therapeutic areas, including immunology and neuroscience.
Education
PhD in Biochemistry from the Biozentrum, University Basel and Master at the University of Milano Bicocca.
Languages
English, Italian
Complete literature list
Oliveira AP, Dimopoulos S, Busetto AG, Christen S, Dechant R, Falter L, Haghir Chehreghani M, Jozefczuk S, Ludwig C, Rudroff F, Schulz JC, González A, Soulard A, Stracka D, Aebersold R, Buhmann JM, Hall MN, Peter M, Sauer U, Stelling J.
Inferring causal metabolic signals that regulate the dynamic TORC1-dependent transcriptome.
Mol Syst Biol. 2015 Apr 17;11(4):802
Stracka D, Jozefczuk S, Rudroff F, Sauer U, Hall MN.
Nitrogen source activates TOR (Target Of Rapamycin) complex 1 via glutamine and independently of Gtr/Rag proteins.
J Biol Chem. 2014 Sep 5;289(36):25010-20
Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN.
mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12526-34
Zinzalla V, Stracka D, Oppliger W, Hall MN.
Activation of mTORC2 by association with the ribosome.
Cell. 2011 Mar 4;144(5):757-68